Cleared Traditional

SCHNEIDER SOFTIP(R) A+(TM) ANGIOGRAPHIC CATHETER (K914009) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K914009 · Schneider Intl., Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1991
Decision
88d
Days
Class 2
Risk

K914009 is an FDA 510(k) clearance for the SCHNEIDER SOFTIP(R) A+(TM) ANGIOGRAPHIC CATHETER. Classified as Catheter, Intravascular, Diagnostic (product code DQO), Class II - Special Controls.

Submitted by Schneider Intl., Ltd. (Plymouth, US). The FDA issued a Cleared decision on December 6, 1991 after a review of 88 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1200 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Schneider Intl., Ltd. devices

Submission Details

510(k) Number K914009 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 09, 1991
Decision Date December 06, 1991
Days to Decision 88 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
37d faster than avg
Panel avg: 125d · This submission: 88d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQO Catheter, Intravascular, Diagnostic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQO Catheter, Intravascular, Diagnostic

All 143
Devices cleared under the same product code (DQO) and FDA review panel - the closest regulatory comparables to K914009.
DESERET GUIDEWIRE INTRODUCER III
K920408 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Apr 1992
CORDIS 5.0 FRENCH SUPER TORQUE CATHETERS
K915836 · Cordis Corp. · Feb 1992
MERIT DISPOSAL DEPOT(TM)
K914208 · Merit Medical Systems, Inc. · Dec 1991
FLOSWITCH(R) HP
K913871 · Boston Scientific Corp · Nov 1991
MERIT CUSTOM KIT
K913682 · Merit Medical Systems, Inc. · Nov 1991
CORDIS DUAL LUMEN PRESSURE MONITORING CATHETER
K914141 · Cordis Corp. · Oct 1991